Neurocrine Bioscienc (NQ: NBIX )
145.01
-2.76
(-1.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Neurocrine Bioscienc
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU5.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://www.investors.com/wp-content/uploads/2017/03/IDS5.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/11/10/nbix.png?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Neurocrine Biosciences
October 30, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600d.jpg)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU2.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
What 22 Analyst Ratings Have To Say About Neurocrine Biosciences
October 06, 2023
Via Benzinga
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://cdn.benzinga.com/files/images/story/2023/10/05/nbix.png?width=1200&height=800&fit=crop)
![](https://www.chartmill.com/images/uploads/Strong_Growth_500_264px_webp_8f1ee6ba5b.webp)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Neurocrine Biosciences's Future
September 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/13/godaddy_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/09/12/nbix.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Analyst Ratings for Neurocrine Biosciences
August 21, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Analyst Ratings for Neurocrine Biosciences
August 02, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Neurocrine Biosciences
July 31, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2022/08/Stock-neurocrinebio-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/08/21/nbix.png?width=1200&height=800&fit=crop)
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
August 21, 2023
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.